People · Operator
Named in public records as an officer, director or promoter · active 2011–2014 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oculeve, Inc. | — | Other Health Care | Series B | $33.2M | $368.9M | 2011 |
D. Michael Ackermann, PhD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside D. Michael Ackermann, PhD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ali Behbahani | 1 | 17 |
| Brook Byers | 1 | 13 |
| William Link | 1 | 11 |
| Mark Blumenkranz | 1 | 3 |
| William J. Link, PhD | 1 | 1 |
| James J. Loudin | 1 | 1 |
| Steve J. Waite | 1 | 1 |
| Brook S. Byers | 1 | 1 |
| Mark S. Blumenkranz, MD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.